Global Microbiomes Market 2024-2028

Global Microbiomes Market 2024-2028

The microbiomes market is forecasted to grow by USD 1,132.78 mn during 2023-2028, accelerating at a CAGR of 22.67% during the forecast period. The report on the microbiomes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diseases, increasing initiatives and investments in microbiome research, and advances in microbiome discovery, therapeutics, and diagnostics.

Technavio's microbiomes market is segmented as below:

By Product

• Probiotics
• Foods
• Prebiotics
• Medical food
• Others

By Application

• Therapeutics
• Diagnostics

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the significant number of collaborations for developing microbiome therapeutics as one of the prime reasons driving the microbiomes market growth during the next few years. Also, growing focus on developing biosensors and genetic circuits and developments in regulatory framework will lead to sizable demand in the market.

The report on the microbiomes market covers the following areas:

• Microbiomes market sizing
• Microbiomes market forecast
• Microbiomes market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microbiomes market vendors that include AOBiome LLC, BiomX Inc., DuPont de Nemours Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., ExeGi Pharma, Ferring BV, MaaT Pharma, OraSure Technologies Inc., Osel Inc., Pendulum Therapeutics Inc., PureTech Health Plc, Qualigen Therapeutics Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Takeda Pharmaceutical Co. Ltd., Vedanta Biosciences Inc., YSOPIA Bioscience, and THERIVA BIOLOGICS INC.. Also, the microbiomes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.